FDA Drug Application (065390) for RIFAMPIN by LANNETT

Back to FDA Applications sponsored by LANNETT

Application Number065390
Product Number001
FormCAPSULE;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRIFAMPIN
Active IngredientRIFAMPIN

Active IngredientCount
List of drugs with Active Ingredient RIFAMPIN6


Back to FDA Applications sponsored by LANNETT